The logo of Johnson & Johnson is seen on the top of a Brussels' office of the company in Diegem, Belgium September 21, 2023. Yves Herman Home Business Healthcare & Pharmaceuticals J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports January 12th, 2025 | 21:35 PM BUSINESS Healthcare & Pharmaceuticals 1 Facebook Twitter Google+ LinkedIn Pinterest By Reuters Johnson & Johnson (JNJ.N) is exploring a bid to acquire Intra-Cellular Therapies Inc (ITCI.O), a biopharmaceutical company, Bloomberg News reported on Sunday citing people familiar with the matter.
Healthcare & Pharmaceuticals August 19th, 2026 Platelets can be chilled and stored for weeks, not days, study shows
Healthcare & Pharmaceuticals August 19th, 2026 Lundbeck sees no slowdown in key drugs despite cautious 2026 outlook, CE...
Healthcare & Pharmaceuticals August 19th, 2026 Ebola cases in Congo exceed 5,000, government data shows
Healthcare & Pharmaceuticals August 18th, 2026 Amylyx drug cuts low blood sugar episodes in bariatric surgery patients ...
Healthcare & Pharmaceuticals August 18th, 2026 WHO says Congo Ebola outbreak can still be brought under control within ...
